Drug intelligence / Profile preview

FID123437

Development stage: Unknown

Overview

FID123437 is an investigational ophthalmic test formulation being evaluated in a clinical study together with a related formulation, FID123440, in healthy volunteers. Publicly available registry information lists it only as a “test formulation” in an eye-drop setting without disclosing its active ingredient, pharmacological class, or sponsor’s proprietary program name, so its precise mechanism of action, molecular modality, and intended therapeutic indication remain undisclosed.

Beyond the preview

Go deeper on FID123437.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FID123437.

Explore the full profile